Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Change in Accured Expenses (2016 - 2020)

Historic Change in Accured Expenses for Forte Biosciences (FBRX) over the last 5 years, with Q4 2020 value amounting to $120000.0.

  • Forte Biosciences' Change in Accured Expenses fell 2405.06% to $120000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$3.2 million, marking a year-over-year decrease of 127610.29%. This contributed to the annual value of $109000.0 for FY2024, which is 4139.78% down from last year.
  • Latest data reveals that Forte Biosciences reported Change in Accured Expenses of $120000.0 as of Q4 2020, which was down 2405.06% from $33000.0 recorded in Q3 2020.
  • Over the past 5 years, Forte Biosciences' Change in Accured Expenses peaked at $3.1 million during Q4 2018, and registered a low of -$3.7 million during Q2 2020.
  • For the 5-year period, Forte Biosciences' Change in Accured Expenses averaged around $284650.0, with its median value being $139000.0 (2019).
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first surged by 205222.93% in 2018, then tumbled by 84778.16% in 2019.
  • Quarter analysis of 5 years shows Forte Biosciences' Change in Accured Expenses stood at $214000.0 in 2016, then tumbled by 173.36% to -$157000.0 in 2017, then surged by 2052.23% to $3.1 million in 2018, then plummeted by 94.85% to $158000.0 in 2019, then fell by 24.05% to $120000.0 in 2020.
  • Its Change in Accured Expenses was $120000.0 in Q4 2020, compared to $33000.0 in Q3 2020 and -$3.7 million in Q2 2020.